Each participant assessed 3 randomly selected vignettes by responding to 2 questions, indicating the minimum health benefit they would require to adopt the RDM as their usual care. The first question was, “How effective would this monitoring have to be in reducing the frequency of hypoglycemic episodes for you to choose it over your current way of monitoring?” The second question was, “How effective would this monitoring have to be in preventing eye complications in the future for you to choose it over your current way of monitoring?”

Participants responded using a 5-point scale (from “it could be much less effective” to “it would have to be much more effective”). We used 2 questions referring to a short-term and long-term health outcomes because people may be biased toward short-term rewards.27

We collected participants’ demographic characteristics and diabetes-related data as well as their perceived intrusiveness for each vignette to examine the association between intrusiveness and minimum required effectiveness (eAppendix 2 in the Supplement). Exploring the association between RDM modalities and intrusiveness was a separate objective and is reported in a different paper.28

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.